To interrogate the selectivity of the C4 and D7 mutein CAR T cells in vivo, we investigated the antitumor activity of the CAR T cells in xenograft models using IL13Rα1-expressing tumor cells. This evidence concerns the gene IL13RA1 and neoplasm.